Adverse effects of erenumab on cerebral proliferative angiopathy: A case report
Authors:
- 19 August 2020
- journal article
- research article
- Published by SAGE Publications in Cephalalgia
- Vol. 41 (1) , 122-126
Abstract
Background: Cerebral proliferative angiopathy is a vascular malformation associated with compromised blood-brain barrier and with migraine-like headache. Treating blood-brain barrier-compromised patients with erenumab, an anti-calcitonin gene-related peptide receptor monoclonal antibody, may be risky. Case: We describe a case of a 22-year-old chronic migraine patient with cerebral proliferative angiopathy who presented to our hospital in status epilepticus 2 d after his first dose of erenumab. Serial magnetic resonance imaging (MRI) studies demonstrated progressive areas of diffusion restriction including the brain tissue adjacent to the cerebral proliferative angiopathy, bilateral white matter and hippocampi. His 6-month post-presentation magnetic resonance imaging was notable for white matter injury, encephalomalacia surrounding cerebral proliferative angiopathy and bilateral hippocampal sclerosis. He remains clinically affected with residual symptoms, including refractory epilepsy and cognitive deficits. Conclusion: The evidence presented in this case supports further investigation into potential deleterious side effects of erenumab in patients with compromised blood-brain barrier, such as individuals with intracranial vascular malformations.Keywords
This publication has 16 references indexed in Scilit:
- Molecular imaging with engineered physiologyNature Communications, 2016
- Facilitation of Synaptic Transmission and Pain Responses by CGRP in the Amygdala of Normal RatsMolecular Pain, 2010
- Cerebral Proliferative AngiopathyStroke, 2008
- Critical Role of Calcitonin Gene-Related Peptide 1 Receptors in the Amygdala in Synaptic Plasticity and Pain BehaviorThe Journal of Neuroscience, 2005
- Elevated Sympathetic Nervous Activity in Mice Deficient in αCGRPCirculation Research, 2001
- Altered neuroadaptation in opiate dependence and neurogenic inflammatory nociception in αCGRP-deficient miceNature Neuroscience, 2001
- Arthritic calcitonin/α calcitonin gene-related peptide knockout mice have reduced nociceptive hypersensitivityPain, 2001
- Mice Lacking α-Calcitonin Gene-Related Peptide Exhibit Normal Cardiovascular Regulation and Neuromuscular DevelopmentMolecular and Cellular Neuroscience, 1999
- Expression in Brain of a Messenger RNA Encoding a Novel Neuropeptide Homologous to Calcitonin Gene-Related PeptideScience, 1985
- Calcitonin and calcitonin gene-related peptide alter the excitability of neurons in rat forebrainPeptides, 1985